275 related articles for article (PubMed ID: 33882393)
1. DNA damage response and repair in pancreatic cancer development and therapy.
Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies.
Mirza-Aghazadeh-Attari M; Ostadian C; Saei AA; Mihanfar A; Darband SG; Sadighparvar S; Kaviani M; Samadi Kafil H; Yousefi B; Majidinia M
DNA Repair (Amst); 2019 Aug; 80():59-84. PubMed ID: 31279973
[TBL] [Abstract][Full Text] [Related]
3. DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives.
Perkhofer L; Gout J; Roger E; Kude de Almeida F; Baptista Simões C; Wiesmüller L; Seufferlein T; Kleger A
Gut; 2021 Mar; 70(3):606-617. PubMed ID: 32855305
[TBL] [Abstract][Full Text] [Related]
4. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
6. Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer.
Hu Y; Guo M
Cancer Sci; 2020 Sep; 111(9):3111-3121. PubMed ID: 32639661
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs, DNA Damage Response, and Cancer Treatment.
He M; Zhou W; Li C; Guo M
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973455
[TBL] [Abstract][Full Text] [Related]
8. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer.
Dreyer SB; Upstill-Goddard R; Paulus-Hock V; Paris C; Lampraki EM; Dray E; Serrels B; Caligiuri G; Rebus S; Plenker D; Galluzzo Z; Brunton H; Cunningham R; Tesson M; Nourse C; Bailey UM; Jones M; Moran-Jones K; Wright DW; Duthie F; Oien K; Evers L; McKay CJ; McGregor GA; Gulati A; Brough R; Bajrami I; Pettitt S; Dziubinski ML; Candido J; Balkwill F; Barry ST; Grützmann R; Rahib L; ; ; Johns A; Pajic M; Froeling FEM; Beer P; Musgrove EA; Petersen GM; Ashworth A; Frame MC; Crawford HC; Simeone DM; Lord C; Mukhopadhyay D; Pilarsky C; Tuveson DA; Cooke SL; Jamieson NB; Morton JP; Sansom OJ; Bailey PJ; Biankin AV; Chang DK
Gastroenterology; 2021 Jan; 160(1):362-377.e13. PubMed ID: 33039466
[TBL] [Abstract][Full Text] [Related]
9. Effect of DNA damage response mutations on prostate cancer prognosis: a systematic review.
Swift SL; Lang SH; White H; Misso K; Kleijnen J; Quek RG
Future Oncol; 2019 Oct; 15(28):3283-3303. PubMed ID: 31535940
[TBL] [Abstract][Full Text] [Related]
10. DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities.
Jurkovicova D; Neophytou CM; Gašparović AČ; Gonçalves AC
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499000
[TBL] [Abstract][Full Text] [Related]
11. Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX.
Sehdev A; Gbolahan O; Hancock BA; Stanley M; Shahda S; Wan J; Wu HH; Radovich M; O'Neil BH
Clin Cancer Res; 2018 Dec; 24(24):6204-6211. PubMed ID: 30131383
[TBL] [Abstract][Full Text] [Related]
12. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
13. DNA damage response inhibitors: An avenue for TNBC treatment.
Jin J; Tao Z; Cao J; Li T; Hu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
[TBL] [Abstract][Full Text] [Related]
14. Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy.
Roger E; Gout J; Arnold F; Beutel AK; Müller M; Abaei A; Barth TFE; Rasche V; Seufferlein T; Perkhofer L; Kleger A
Cells; 2020 Sep; 9(9):. PubMed ID: 32948057
[TBL] [Abstract][Full Text] [Related]
15. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications.
Sadoughi F; Maleki Dana P; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jun; 102():103105. PubMed ID: 33836418
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.
Bartek J; Lukas J; Bartkova J
Cell Cycle; 2007 Oct; 6(19):2344-7. PubMed ID: 17700066
[TBL] [Abstract][Full Text] [Related]
17. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
Bottai G; Pasculli B; Calin GA; Santarpia L
Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
[TBL] [Abstract][Full Text] [Related]
18. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
19. Advances in therapeutic targeting of the DNA damage response in cancer.
Desai A; Yan Y; Gerson SL
DNA Repair (Amst); 2018; 66-67():24-29. PubMed ID: 29715575
[TBL] [Abstract][Full Text] [Related]
20. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.
Darzynkiewicz Z; Traganos F; Wlodkowic D
Eur J Pharmacol; 2009 Dec; 625(1-3):143-50. PubMed ID: 19836377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
